48
Participants
Start Date
November 30, 2016
Primary Completion Date
July 8, 2019
Study Completion Date
July 8, 2019
PGT121 3mg/kg IV
3mg/kg administered by IV Infusion
PGT121 10mg/kg IV
10mg/kg administered by IV infusion
PGT121 30mg/kg IV
30mg/kg administered by IV infusion
PGT121 3mg/kg SC
"3mg/kg administered by SC injection~Placebo: None"
Placebo (0.9% Sodium Chloride Injection USP (Saline))
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
Beth Israel Deaconess Medical Center, Boston MA
UNKNOWN
Ragon Institute of MGH, MIT and Harvard, Boston MA
UNKNOWN
University of Texas Health, Houston AIDS Research Team (HART), Houston TX
UNKNOWN
Mills Clinical Research, Los Angeles CA
UNKNOWN
Orlando Immunology Clinic, Orlando FL
UNKNOWN
International AIDS Vaccine Initiative
NETWORK